mepa8 Get alerts

American Regent recalls three epinephrine 30 mL vial lots over particulates and cracked vials

The company says it has received no adverse event reports tied to the recalled multi-dose vials, which were distributed nationwide between September 2025 and July 2026.

Mepa8 headline card: American Regent recalls three epinephrine 30 mL vial lots over particulates and cracked vials

Key takeaways

  • American Regent announced on September 3, 2026, a voluntary nationwide recall of three lots of Epinephrine Injection, USP 30 mg/ 30 mL (1 mg/mL) in multi-dose vials.
  • The stated reasons are customer complaints of leaking and cracked vials and particulate matter identified as Nylon, Cellulosic, Acrylic, Polyethylene and Glass.
  • The company said it has not received any reports of adverse events related to the recall.
  • The lots were distributed nationwide in the United States between September 04, 2025 and July 31, 2026.
  • For crews: the affected vials carry NDC 0517-3030-01 and lot numbers 25128L1C0, 25280L1C0 or 26108L1C0.

American Regent, Inc. announced on September 3, 2026, a voluntary nationwide recall of three lots of Epinephrine Injection, USP 30 mg/ 30 mL (1 mg/mL) in multi-dose vials, according to a company announcement posted by the Food and Drug Administration. The recall extends "to the consumer level," the announcement says. [1]

The New Albany, Ohio, company gave two reasons. Customers complained of leaking and cracked vials, which the company said results in "lack of assurance of sterility." The firm's own investigation then found particulate matter, which it identified as Nylon, Cellulosic, Acrylic, Polyethylene and Glass. [1]

"To date, American Regent has not received any reports of adverse events related to this recall," the company wrote. [1]

What the records show

The recalled product is a 30 mL multiple-dose vial containing 1 mg/mL of epinephrine, sold under NDC 0517-3030-01. The announcement describes the drug as a clear, colorless, sterile solution. All three lots were distributed nationwide in the United States, the record says. [1]

LotDistribution beganDistribution endedExpiry
25128L1C0September 04, 2025December 18, 2025August 2026
25280L1C0December 16, 2025April 17, 2026October 2026
26108L1C0June 15, 2026July 31, 2026July 2027

Two of the lots carry expiry dates that have already passed. The third, lot 26108L1C0, is labeled to expire in July 2027. [1]

The company's risk statement says intravenous administration of product containing particulate matter "may lead to serious adverse health consequences." It says particles can block blood vessels and cause clotting, cutting off blood flow to vital organs, and can lead to pulmonary embolism, permanent organ damage or death. The statement also lists vein irritation at the site, inflammatory reactions, worsening of existing infections and allergic reactions. [1]

On the cracked vials, the company said a compromised container can lose sterility and become contaminated, which it called a serious risk for patients. [1]

American Regent said it is notifying distributors and customers by letter and arranging return or replacement of recalled product. The announcement says distributors, retailers and healthcare facilities holding the product should stop using it and return it to the place of purchase or discard it. The company lists a customer service line, 800-645-1706, for return, replacement and credit information. [1]

The announcement states that the recall is being conducted with the FDA's knowledge. The FDA page notes that the agency posts company announcements as a public service and does not endorse the product or the company. [1]

Why it matters for EMS

The announcement says the product is indicated for emergency treatment of Type I allergic reactions, including anaphylaxis. It is also indicated to raise mean arterial blood pressure in adults with hypotension associated with septic shock. [1]

The vials are given intravenously, intramuscularly or subcutaneously, and are to be used "by or under the direction of a physician," according to the record. The company's risk statement on particulate matter addresses the intravenous route specifically. Its statement on cracked vials and loss of sterility is not limited to a route. [1]

The distribution window runs from September 2025 through July 2026, and the announcement names healthcare facilities among the holders of the product. The record does not name any EMS agency, hospital or distributor that received the lots. EMS clinicians follow local protocols and medical direction. [1]

What the records do not tell us

  • The announcement does not say how many vials are in the three lots or how many complaints of leaking or cracked vials the company received. [1]
  • It does not say what caused the cracking, or how the particulate matter entered the product. [1]
  • It does not say where the vials were manufactured. [1]
  • The record carries no FDA recall classification. The company announcement date and FDA publish date fields in the page summary are blank in the copy reviewed; the date of September 3, 2026, comes from the announcement text. [1]
  • The record does not say whether other American Regent epinephrine lots or presentations were examined, or whether supply of the product is affected. [1]
  • The absence of adverse event reports is the company's statement as of its announcement. The record includes no independent FDA assessment. [1]

Questions readers ask

Which American Regent epinephrine lots are recalled?

The recall covers lots 25128L1C0, 25280L1C0 and 26108L1C0 of Epinephrine Injection, USP 30 mg/ 30 mL (1 mg/mL) in multi-dose vials, NDC 0517-3030-01, according to the company announcement posted by the FDA.

Why is American Regent recalling epinephrine vials?

The company said it received customer complaints of leaking and cracked vials, resulting in lack of assurance of sterility. Its investigation also found particulate matter identified as Nylon, Cellulosic, Acrylic, Polyethylene and Glass.

Has anyone been harmed by the recalled epinephrine?

American Regent said in its announcement that it has not received any reports of adverse events related to the recall. The record contains no independent FDA assessment.

When were the recalled epinephrine lots distributed?

The three lots were distributed nationwide in the United States between September 04, 2025 and July 31, 2026, according to the announcement. Their labeled expiry dates are August 2026, October 2026 and July 2027.

Sources

  1. FDA: American Regent, Inc. company announcement, voluntary nationwide recall of three lots of Epinephrine Injection, USP 30 mg/ 30 mL (1 mg/mL) — fda.gov (2026-11-17). fda.gov/safety/recalls-market-withdrawals-safety-alerts/american-regen
How this story was made Drafted by Mepa8's AI newsroom from the 1 record listed above and nothing else. Before publication a verification program confirmed that every number and quotation in the story appears in those records, that no passage was copied from them, and that every cited link opens. Editor: Ryan Bolden, EMS professional, who reviews published stories and handles corrections. Medical review pending. How we use AI · Report an error

This is news, not medical advice. EMS clinicians: follow your local protocols and medical direction.

Free alerts

Know about the next recall or outbreak the day it is posted.

One email when a story touches EMS equipment, medications or public health. Plus the free 6am briefing if you want it.

Send me